Pharmacological properties of thiazolinobutazone (LAS 11871). I. Anti-inflammatory effects.
D000038:Abscess / Q000139:chemically induced / Q000188:drug therapy; D000284:Administration, Oral; D000315:Adrenalectomy; D000818:Animals; D001920:Bradykinin; D001986:Bronchial Spasm / Q000139:chemically induced / Q000188:drug therapy; D002351:Carrageenan; D004487:Edema / Q000139:chemically induced / Q000188:drug therapy; D004890:Erythema / Q000188:drug therapy / Q000209:etiology; D005260:Female; D006099:Granuloma / Q000188:drug therapy / Q000209:etiology; D006168:Guinea Pigs; D007275:Injections, Intravenous; D007279:Injections, Subcutaneous; D008297:Male; D010653:Phenylbutazone / Q000031:analogs & derivatives* / Q000627:therapeutic use; D051381:Rats; D013844:Thiazoles / Q000627:therapeutic use*; D014466:Ultraviolet Rays
D013844:Thiazoles; D002351:Carrageenan; D010653:Phenylbutazone; D001920:Bradykinin